RESI’s partnering system is a powerful tool—but only if you know how to use it. Join the LSN team as we walk through how to navigate the platform, target the right investor fit, manage your outreach, and make the most of every meeting. We will also share our recommended strategy for follow-ups and how to...
AI Innovations Transforming the Future of Human Health Dive into the transformative world of artificial intelligence and its pivotal role in maintaining our position as a global leader at An Evening with Thought Leaders, August 20th in San Diego. This exclusive event brings together distinguished experts from academia, medtech, biotech, and diagnostics to discuss and...
Join Us for the BVS and BioMed Realty Biotech Community Event! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. The vendor fair is held at The Forum, in the same building as Amgen and next to Genentech, right in...
We’re headed to the Boston area August 20th 2025 and we’re excited to host an event in Cambridge, MA for the first time. We’ve chosen the Lamplighter Brewing Co.’s CX Taproom which is less than a mile north east of Kendall Square and accessible via the T Green Line. We’ll have the beautiful, window-filled upstairs...
Clinical trial agreements are the backbone of every relationship between sponsors, CROs, and the research institution. Some of the biggest challenges when handlings these agreements are budget negotiation, communication transparency, language determination, and technological advancements. Are you prepared to learn the best strategies on how to accelerate your CTA negotiations? Save the date for August...
The ever-evolving complexities accompanying innovative clinical trial design and implementation require a more strategic and exacting relationship for sites and sponsors. In addition to needing a deep understanding of unique study design to execute it accurately, sites are also facing technology challenges, more diverse patient populations and regulatory scrutiny on data collection and quality. Empowering...
FREE Webinar • Monday, August 25, 2025 • 11:00 AM ET Bring adenovirus-based therapies to the clinic faster without sacrificing quality. Go behind the scenes of a real program that moved efficiently from concept to CTA, as 3PBIOVIAN experts share pitfalls to avoid and the strategies that actually work. You’ll learn how to: • Map...
FREE Webinar • Tuesday, August 26, 2025 • 11:00 AM ET Unlock higher viral vector yields and efficiency with upstream intensification. Learn how Repligen’s TFDF® system, combined with Catalent’s HEK293 cell line and OTS plasmids, delivers robust improvements in AAV and LVV production—up to 9-fold and 30-fold increases—while preserving quality. You’ll learn how to: •...
Biotech’s biggest blind spot isn’t science — it’s equity. And the next breakthrough hub isn’t Boston or San Francisco, but Southwest Philadelphia. Join Dr. Tia Lyles-Williams — founder of LucasPye BIO, HelaPlex, and Jackson Taylor Therapeutics — for a live conversation on: 🔹 Building the first life science park led by an African American Queer...
Biotech Networks is very excited to be hosting an event in our NINTH US city, Philadelphia! We built the PA/NY/NJ hub online and understand the broad geography that it encompasses. Philadelphia is a natural first step for us to visit, as NY and NJ offer some challenges as to where to host an event. Eventually...
Join us for a 2-hour virtual expo designed to help clinical trial professionals discover and compare the best Electronic Data Capture (EDC), electronic Clinical Outcome Assessment (eCOA), & Data Management technologies on the market, without the time, cost, or travel of traditional conferences. Whether you are mid-trial or preparing for your next protocol, this free...
FREE Webinar • Wednesday, August 27, 2025 • 11:00 AM ET Scaling a biologic from development to commercial production often exposes cracks in upstream process design — especially when traditional seed trains, media prep capacity, or facility layout can't support higher-volume output. This "scale-up gap" can delay tech transfer, increase batch failure risk, and force...
